Overcoming time-varying confounding in self-controlled case series with active comparators: application and recommendations.

IF 5 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Anna Schultze, Jeremy Brown, John Logie, Marianne Cunnington, Gema Requena, Iain A Gillespie, Stephen J W Evans, Ian Douglas, Nicholas Galwey
{"title":"Overcoming time-varying confounding in self-controlled case series with active comparators: application and recommendations.","authors":"Anna Schultze, Jeremy Brown, John Logie, Marianne Cunnington, Gema Requena, Iain A Gillespie, Stephen J W Evans, Ian Douglas, Nicholas Galwey","doi":"10.1093/aje/kwae216","DOIUrl":null,"url":null,"abstract":"<p><p>Confounding by indication is a key challenge for pharmacoepidemiologists. Although self-controlled study designs address time-invariant confounding, indications sometimes vary over time. For example, infection might act as a time-varying confounder in a study of antibiotics and uveitis, because it is time-limited and a direct cause of both receipt of antibiotics and uveitis. Methods for incorporating active comparators in self-controlled studies to address such time-varying confounding by indication have only recently been developed. In this paper, we formalize these methods and provide a detailed description for how the active comparator rate ratio can be derived in a self-controlled case series: either by explicitly comparing the regression coefficients for a drug of interest and an active comparator under certain circumstances using a simple ratio approach or through the use of a nested regression model. The approaches are compared in 2 case studies, one examining the association between thiazolidinedione use and fractures and one examining the association between fluoroquinolone use and uveitis, using the United Kingdom's Clinical Practice Research Datalink. Finally, we provide recommendations for the use of these methods, which we hope will support the design, execution, and interpretation of self-controlled case series using active comparators and thereby increase the robustness of pharmacoepidemiologic studies. This article is part of a Special Collection on Pharmacoepidemiology.</p>","PeriodicalId":7472,"journal":{"name":"American journal of epidemiology","volume":" ","pages":"220-225"},"PeriodicalIF":5.0000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11735952/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/aje/kwae216","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Confounding by indication is a key challenge for pharmacoepidemiologists. Although self-controlled study designs address time-invariant confounding, indications sometimes vary over time. For example, infection might act as a time-varying confounder in a study of antibiotics and uveitis, because it is time-limited and a direct cause of both receipt of antibiotics and uveitis. Methods for incorporating active comparators in self-controlled studies to address such time-varying confounding by indication have only recently been developed. In this paper, we formalize these methods and provide a detailed description for how the active comparator rate ratio can be derived in a self-controlled case series: either by explicitly comparing the regression coefficients for a drug of interest and an active comparator under certain circumstances using a simple ratio approach or through the use of a nested regression model. The approaches are compared in 2 case studies, one examining the association between thiazolidinedione use and fractures and one examining the association between fluoroquinolone use and uveitis, using the United Kingdom's Clinical Practice Research Datalink. Finally, we provide recommendations for the use of these methods, which we hope will support the design, execution, and interpretation of self-controlled case series using active comparators and thereby increase the robustness of pharmacoepidemiologic studies. This article is part of a Special Collection on Pharmacoepidemiology.

克服自控病例系列中的时变混杂:应用与建议》。
适应症混杂是药物流行病学家面临的一个主要挑战。虽然自控研究设计可以解决时间不变的混杂因素,但适应症有时会随时间而变化。例如,在一项关于抗生素和葡萄膜炎的研究中,感染可能会成为随时间变化的混杂因素,因为感染是有时间限制的,并且是接受抗生素和葡萄膜炎的直接原因。在自控研究中加入主动比较者以解决这种因适应症而产生的时变混杂因素的方法最近才被开发出来。在本文中,我们正式介绍了这些方法,并详细描述了如何在自控病例系列研究(SCCS)中得出活性参照物的比率:在某些情况下,可以使用简单的比率方法明确比较相关药物和活性参照物的回归系数,或者使用嵌套回归模型。我们在两个案例研究中对这两种方法进行了比较,一个案例研究了噻唑烷二酮类药物与骨折之间的关系,另一个案例使用英国临床实践研究数据链接研究了氟喹诺酮类药物与葡萄膜炎之间的关系。最后,我们对这些方法的使用提出了建议,希望这些建议能为使用活性比较物的 SCCS 的设计、执行和解释提供支持,从而提高药物流行病学研究的稳健性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of epidemiology
American journal of epidemiology 医学-公共卫生、环境卫生与职业卫生
CiteScore
7.40
自引率
4.00%
发文量
221
审稿时长
3-6 weeks
期刊介绍: The American Journal of Epidemiology is the oldest and one of the premier epidemiologic journals devoted to the publication of empirical research findings, opinion pieces, and methodological developments in the field of epidemiologic research. It is a peer-reviewed journal aimed at both fellow epidemiologists and those who use epidemiologic data, including public health workers and clinicians.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信